Poland· PL-100250478
Levetiracetam Teva
A levetiracetam product containing levetiracetamum, registered in Poland by Teva B.V.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Levetiracetam is registered in 19 of 19 countries.
Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Levetiracetam · ATC N03AX14
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levetiracetam costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levetiracetam · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$3.10
- CH Switzerland$2.54
- IT Italy$2.14
- FR France$1.19
The record
At a glance
URPL (Poland)- Active substance
- Levetiracetamum
- Manufacturer
- Teva B.V.
- Country
- Poland (PL)
- ATC code
- N03AX14
- ATC class
- Levetiracetam
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990879106
- gtin05909990879137
- gtin05909990879144
- gtin05909990958443
- gtin05909990879069
- gtin05909990879076
- gtin05909990879083
- gtin05909990879090
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for levetiracetam.
Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levetiracetam · interactions on record
258 records
- 50 moderate
- 3 minor
- 164 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levetiracetam in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDRETACENSandoz s.r.o., Praha
- SpainEVEXIBAM 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGIntas Third Party Sales 2005 S.L.
- United StatesKeppraUCB, Inc.
- SwedenKeppra 250 mg Filmdragerad tablettUCB Pharma S.A.
- BelgiumKeppra 250 mgPI Pharma
- NetherlandsDRETACEN 250 mg, filmomhulde tablettenSandoz B.V.
- FinlandKeppraUCB Pharma SA
- FranceKEPPRA 250 mg, comprimé pelliculéUCB PHARMA BELGIQUE
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Levebon, Levetiracetam +pharma
- Belgium · Larofec, Levetiracetam A.Forall
- Bulgaria · Levebon, Леветиракон Pharmacons
- Cyprus · Levetiracetam Noridem, Lyberen
- Czechia · Dretacen, Epiletam
- Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
- Denmark · Kevesy, Levetiracetam ”1a Farma”
- Estonia · Levetiracetam Zentiva, Normeg
- Spain · Laurak, Levetiracetam Almus
- Finland · Larofec, Levetiracetam 1a Farma
- France · Levetiracetam Accord, Levetiracetam Aguettant
- United Kingdom (Northern Ireland) · Desitrend, Genlev
- Greece · Ession, Kepricet
- Croatia · Levetiracetam Kalceks, Lyvam
- Hungary · Epiletam, Levetiracetam Kabi
- Ireland · Larofec, Levetiracetam Brillpharma
- Iceland · Keppra, Levetiracetam Accord
- Italy · Epitiram, Grifoxina
- Liechtenstein · Keppra, Levetiracetam Accord
- Lithuania · Dretacen, Levetiracetam Kalceks
- Luxembourg · Larofec, Levetiracetam Micro Labs
- Latvia · Levetiracetam Kalceks
- Malta · Levetiracetam Accord, Levetiracetam Aurobindo
- Netherlands · Dretacen, Larofec
- Norway · Keppra, Larofec
- Portugal · Cinaz, Laurak
- Romania · Levetiracetam Accord, Levetiracetam Arena
- Sweden · Levebon, Levetiracetam
- Slovenia · Levetiracetam Kalceks
- Slovakia · Epiletam, Levetiracetam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d19263f7-4db1-4ddd-8378-8652cd367bdf GET /v1/drugs/d19263f7-4db1-4ddd-8378-8652cd367bdf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909990879069 ¦ Rp ¦ EU/1/11/701/001 ¦ 67382\n30 tabl.\n05909990879076 ¦ Rp ¦ EU/1/11/701/002 ¦ 67383\n50 tabl.\n05909990879083 ¦ Rp ¦ EU/1/11/701/003 ¦ 67384\n50 tabl. (50 x 1)\n05909990879090 ¦ Rp ¦ EU/1/11/701/004 ¦ 67385\n60 tabl.\n05909990879106 ¦ Rp ¦ EU/1/11/701/005 ¦ 67386\n100 tabl.\n05909990879137 ¦ Rp ¦ EU/1/11/701/006 ¦ 67387\n120 tabl.\n05909990879144 ¦ Rp ¦ EU/1/11/701/007 ¦ 67388\n200 tabl.\n05909990958443 ¦ Rp ¦ EU/1/11/701/029 ¦ 74727\n20 tabl.",
"substance": null,
"common_name": "Levetiracetamum",
"pl_product_id": "100250478",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about levetiracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.